Droxidopa Impurity 20 | CAS 2097541-16-5 - Request Quote
Droxidopa Impurity 20
| SZ CAT No: | SZ-D057021 |
| CAS No | 2097541-16-5 |
| Mol.F. | C28H29NO5 |
| Mol.Wt. | 459.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Droxidopa Impurity 20 is chemically Tert-butyl (4S,5R)-5-(3,4-bis(benzyloxy)phenyl)-4,5-dihydrooxazole-4-carboxylate. Droxidopa Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Droxidopa Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Droxidopa.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2097541-16-5
Purchase 2097541-16-5
Order 2097541-16-5
Enquire 2097541-16-5
price of 2097541-16-5
2097541-16-5 Supplier
2097541-16-5 Manufacturer
2097541-16-5 Exporter
buy high quality Droxidopa Impurity 20
Purchase Droxidopa Impurity 20
Droxidopa Impurity 20 suppliers
Droxidopa Impurity 20 manufacturers
Droxidopa Impurity 20 price
Order Droxidopa Impurity 20
Enquire Droxidopa Impurity 20
Droxidopa Impurity 20 cost
Droxidopa Impurity 20 Supplier
Droxidopa Impurity 20 Distributor
Droxidopa Impurity 20 for Method Validation
Droxidopa Reference Standard
Droxidopa Impurity 20 for ANDA Filing
Droxidopa Impurity 20 for Forced Degradation Studies
Droxidopa Impurity 20 Identification Standards
Droxidopa Impurity 20 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


